DONGWHA PHARM.CO.,LTD Logo

DONGWHA PHARM.CO.,LTD

Develops, manufactures, and sells a diverse portfolio of healthcare products globally.

000020 | KO

Overview

Corporate Details

ISIN(s):
KR7000020008
LEI:
Country:
South Korea
Address:
서울특별시 중구 서소문로9길 20, 중구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1897, Dongwha Pharm is a pioneering pharmaceutical company with a long history of serving public health. The company is engaged in the research, development, manufacturing, and sale of a diverse portfolio of healthcare products. Its offerings span multiple categories, including prescription pharmaceuticals (ethical drugs), over-the-counter (OTC) medicines, medical devices, quasi-drugs, cosmetics, and health functional foods and beverages. As a fully integrated company, Dongwha Pharm operates its own R&D centers, manufacturing facilities, and a nationwide sales and marketing network. It is committed to innovation, continuously developing new drugs and launching consumer health brands while also exporting its products to global markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.0 MB
2025-08-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.5 KB
2025-07-31 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.2 KB
2025-07-15 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 13.6 KB
2025-06-30 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 11.2 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 851.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.5 MB
2025-04-30 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.1 KB
2025-04-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-16 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 52.2 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.1 KB
2025-03-26 00:00
Post-Annual General Meeting Information
[기재정정]정기주주총회결과
Korean 31.0 KB
2025-03-26 00:00
Board/Management Information
대표이사(대표집행임원)변경(안내공시)
Korean 6.0 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.3 KB
2025-03-24 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 130.7 KB

Automate Your Workflow. Get a real-time feed of all DONGWHA PHARM.CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONGWHA PHARM.CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONGWHA PHARM.CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany
BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia
BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom
BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland
BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden
BIOVIC
BIOVIE INC. Logo
Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
AI-driven biopharma developing treatments for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology drugs targeting mutation families in lung and brain cancers.
United States of America
BDTX
BL Pharmtech Corp. Logo
Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.
South Korea
065170

Talk to a Data Expert

Have a question? We'll get back to you promptly.